Tirzepatide (Mounjaro, Zepbound) works through a related but distinct mechanism as a dual GIP/GLP-1 receptor agonist
Many patients notice improved focus, sharper memory, better sleep patterns, and even healthier hair, skin, and nails with regular shots
Novos general counsel John Kuckelman told CNBC it may have been accurate for Lilly to boast about Zepbounds greater efficacy before the 7.2 milligram dose of Wegovy became available, but it is no longer accurate to say that. Novos suit says Lilly acknowledges a higher dose of Wegovy in a brief footnote in the television ad, but it says the footnote is ambiguous, confusing, virtually illegible, and wholly inadequate. key background Novo Nordisk and Eli Lilly, chief rivals in the booming GLP-1 industry, have struggled for dominance over the obesity medication market, with Novos market share slipping from an early lead
So the U.S
Avoiding Food and Drink Interactions Avoid taking Adderall with acidic foods, drinks, or vitamin C, as these can reduce its effectiveness
World Obesity Atlas 2023